RTW INVESTMENTS, LP bought OBIO
April 27, 2026 · Form 4 insider transaction
RTW INVESTMENTS, LP bought 1,250,032 shares of Orchestra BioMed Holdings, Inc. at $0.00 per share, a transaction worth $125.00. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
On April 27, 2026, the RTW Funds exercised Pre-Funded Warrants to purchase an aggregate of 1,250,032 shares of the Issuer's common stock for $0.0001 a share. The RTW Funds exercised the Pre-Funded Warrants on a cashless basis, resulting in the Issuer's withholding 32 of such shares to satisfy the exercise price of the Pre-Funded Warrants, and the issuance to the RTW Funds of an aggregate of 1,250,000 shares.; Held by certain affiliated funds (the "RTW Funds") managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.